It should be mentioned that the implication of the AVP pathway in the pathogenesis of MetS and insulin resistance is complex, perhaps involving not only the AVP secretion but also genetic and non-genetic effects of both V1a and V1b receptors in the liver and pancreas. This evidence concerns the gene AVPR1B and metabolic syndrome.